Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

948 public trials 78 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia

NCT00404001

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Microbia Investigational Site Birmingham, Alabama, United States

Microbia Investigational Site Los Angeles, California, United States

Microbia Investigational Site Walnut Creek, California, United States

Microbia Investigational Site New Port Richey, Florida, United States

View all 20 locations

View Trial Details

Completed

Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults

NCT00422266

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: National Thermal Power Corporation Delhi, Badarpur, India

View Trial Details

Completed

The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids

NCT00526682

Conditions: Body Weight, Body Weight Changes, Dyslipidemia, +11 more
Locations: Not specified

View Trial Details

Completed

Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

NCT00349128

Conditions: Dyslipidemia/Glucose Metabolism Disorder, Dyslipidemias, Glucose Metabolism Disorders, +3 more
Locations: Site 201 Katowice, Poland

Site 203 Katowice, Poland

Site 202 Warsaw, Poland

Site 204 Zabrze, Poland

View all 51 locations

View Trial Details

Completed

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

NCT00490178

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +6 more
Locations: Site 3 Marseille, France

Site 1 Nantes, France

Site 2 Tours, France

View Trial Details

Completed

Acceptability of a Fixed Combination of Fenofibrate and Metformin

NCT00348725

Conditions: Dyslipidemia/Glucose Metabolism Disorder, Dyslipidemias, Glucose Metabolism Disorders, +3 more
Locations: Site 24 Anzin, France

Site 23 Bachant, France

Site 21 Bauné, France

Site 32 Bersée, France

View all 25 locations

View Trial Details

Completed

Lifestyle Intervention in Primary Health Care - the Björknäs Study

NCT00486941

Conditions: Behavior, Body Weight, Cardiovascular Diseases, +19 more
Locations: Björknäs Health Centre Boden, Sweden

View Trial Details

Completed

ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

NCT00493506

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +23 more
Locations: Laboratory of Nutrition and Nutritional Biochemistry (LNNB), Department of Biochemistry, University of Yaounde I Yaoundé, Cameroon

View Trial Details

Completed

Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

NCT00471549

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +11 more
Locations: Not specified

View Trial Details

Completed

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

NCT00169871

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Lipid Research Center, CHUL Research Center Sainte-Foy, Quebec, Canada

View Trial Details

Dyslipidemias

Dyslipidemias trial results

Related conditions